MTOR and endometrial cancer: Although there is a lack of direct evidence that abnormal autophagy is involved in progesterone (P4) resistance in ectopic endometrial cells, mammalian target of rapamycin (mTOR), a putative upstream signalling component of autophagy, is overactivated in progesterone-resistant endometrial cancer cells (Liu et al., 2017).